First iPhone app for ophthalmic image management

Article

The mobile version of Topcon Medical Systems's EyeRoute Image Management Suite is now available as a dedicated iPhone application

The mobile version of Topcon Medical Systems’s EyeRoute Image Management Suite is now available as a dedicated iPhone application in North America. It was first presented in October 2009 at the American Academy of Ophthalmology Meeting in San Francisco.

Ophthalmologists who have incorporated the EyeRoute in their practice, can access images and reports from any 3GS-compatible iPhone, iPod touch, or iPad, via EyeRoute Mobile.

Patient images stored in EyeRoute can be listed by modality or visit date, and reviewed, panned, zoomed, enhanced, and annotated with text and audio dictation options. Once reviewed, a smart integrated messaging system allows users to share information with other EyeRoute users through the network.

Dr Julia Haller, Ophthalmologist-in-Chief at Wills Eye Hospital, among the very first users of the EyeRoute Mobile, said: "I view this new addition to the EyeRoute suite as a veritable boon in enabling practitioners to stay connected wherever they are in the world. Now, more than ever before, with Topcon's EyeRoute iPhone application all members of the Wills Eye network, including those working in, remote areas can connect with our EyeRoute patient database on-the-go."

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.